NCT06046690

Brief Summary

Inspiratory Muscle Training(IMT) increases the strength and endurance of the inspiratory muscles, exercise capacity, quality of life and reduces the perception of dyspnea. It has been reported in the literature that it also has an effect on mechanical ventilated patients in the intensive care unit. In patients on mechanical ventilation, IMT is applied with modification of trigger sensitivity and with an external device. The aim of this study is to compare the effects of inspiratory muscle training with external device and MV modification on respiratory muscle strength and intubation time

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 22, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 21, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

November 1, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 10, 2024

Completed
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 15, 2024

Completed
Last Updated

January 23, 2025

Status Verified

January 1, 2024

Enrollment Period

1 year

First QC Date

August 22, 2023

Last Update Submit

January 20, 2025

Conditions

Keywords

İnspiratory muscle trainingintensive carerehabilitationmechanical ventilation

Outcome Measures

Primary Outcomes (11)

  • Assesment of respiratory muscle strength

    Negative inspiratory force (NIF) is the maximum pressure that can be generate against an occluded airway and is a marker of respiratory muscle function and strength. The Negative Inspiratory Force index (NIF) measures the patient's maximum inhalation effort after exhaling. This value is also known as the Maximum Inspiratory Pressure (MIP). Patients with a NIF \< -30mbar (more negative) can in all probability be weaned successfully, while those with a NIF of up to -20mbar (less negative) will most probably prove unsuccessful and weaning is more likely to fail. The NIF is measured as a pressure against PEEP (Positive end-expiratory airway pressure).

    It will be measured before training and before extubation.

  • Assesment of lung volume assessment

    While in CPAP mode, the participants will be instructed to take deep breaths and exhale for about 1 minute with Pressure Support value 10 cmH2O and PEEP 5 cmH2O. At this time, the highest inspiratory tidal volume and expiratory tidal volume in milliliters (ml) will be recorded.

    Measurements will be taken before and after daily exercises from the start of education until the day of extubation, an average 10 days

  • Assesment of the respiratory status

    Rapid Shallow Breathing Index (RSBI) is calculated by dividing the respiratory rate (number of breaths) by the tidal volume (volume of air in each breath). The formula is as follows: RSBI = Respiratory Rate / Tidal Volume Low RSBI values indicate that the patient tolerates mechanical ventilation well and there is minimal fatigue in the respiratory muscles. High RSBI values may suggest fatigue and increased strain on ventilation.

    It will be measured before training and before extubation.

  • Assesment of the oxygenation status

    Oxygenation Index (OI) is used to evaluate a mechanically ventilated patient's oxygenation (oxygen level) in relation to the need for respiratory support. The formula is as follows: OI = (Oxygen Pressure / Fraction of Inspired Oxygen) \* Mean Airway Pressure Low OI values indicate good oxygenation and low requirement for respiratory support, while high OI values may indicate poor oxygenation and a greater need for respiratory assistance.

    It will be measured before training and before extubation.

  • Assesment of physical status

    The PFIT-S is a specific assessment tool designed to measure the physical function of patients in the intensive care unit (ICU). It aims to evaluate the patient's ability to perform various physical tasks and activities during their ICU stay. The PFIT-S helps healthcare professionals assess the patient's functional status, track their progress, and guide rehabilitation interventions. It includes 4 items: amount of assistance for sit-to-stand transfers, strength for shoulder flexion, strength for knee extension, marching in place.The PFIT-s scores range from 0 (able to perform strength testing only with a maximal score of 2/5 for shoulder and knee) to 10 (performance without any difficulty)

    It will be measured before training and before extubation.

  • Assesment of Mechanical ventilator parameters

    Before the training, the mechanical ventilator mode, PEEP (Positive End-Expiratory Pressure), Pressure support values in cmH2O of the participants will be recorded.

    Measurements will be taken before and after daily exercises from the start of education until the day of extubation, an average 10 days

  • Assesment of Partial Pressure of Oxygen(PaO2) and Partial Pressure of Carbon dioxide(PaCO2) in Arterial Blood

    PaO2(mmHg) and PaCO2(mmHg) in the blood represents the respective concentrations of these gases dissolved in the blood plasma. These values are crucial indicators of respiratory function and metabolic balance within the body. Monitoring these partial pressures is fundamental in assessing respiratory efficiency and guiding appropriate medical interventions for patients with various health conditions.

    Measurements will be taken before and after daily exercises from the start of education until the day of extubation, an average 10 days

  • Assesment Concentration of Bicarbonate(HCO3) in Arterial Blood

    HCO3 (meq/L) aids in discerning the extent or seriousness of anomalies, distinguishing between acute and chronic abnormalities, and identifying whether the primary condition is metabolic or respiratory in nature. Automated blood gas analyzers are used to analyze blood gas samples and define HCO3 values

    Measurements will be taken before and after daily exercises from the start of education until the day of extubation, an average 10 days

  • Assesment pH values

    A pH of 7.37 is classified as acidosis, while a pH of 7.42 is categorized as alkalemia. Automated blood gas analyzers are used to analyze blood gas samples and define pH values

    Measurements will be taken before and after daily exercises from the start of education until the day of extubation, an average 10 days

  • Assesment of Minute Ventilation

    While in CPAP mode, the participants will be instructed to take deep breaths and exhale for about 1 minute with Pressure Support value 10 cmH2O and PEEP 5 cmH2O. The highest minute ventilation in liters per minute (l/min), will be recorded

    Measurements will be taken before and after daily exercises from the start of education until the day of extubation, an average 10 days

  • Assesment Fraction of Inspired Oxygen(FiO2)

    FiO2, refers to the concentration of oxygen in the air being delivered to a patient during mechanical ventilated. It plays a crurial role in managing patients with respiratory conditions, as it helps healthcare professionals adjust oxygen therapy to maintain adequate oxygenation and prevent complications like hypoxia or oxygen toxicity. Precise monitoring and adjustment of FiO2 levels are essential in optimizing patient care and outcomes in clinical settings.Before the training FiO2 in % of the participants will be recorded.

    Measurements will be taken before and after daily exercises from the start of education until the day of extubation, an average 10 days

Study Arms (2)

MV Modification Group

EXPERIMENTAL

Participant in this group will be applied inspiratory muscle training with trigger system modification in addition to conventional chest physiotherapy consisting of respiratory control, diaphragmatic breathing, costal expansion exercises, postural drainage, effective coughing, in-bed ROM exercises and mobilization, twice a day until the day of extubation.

Device: Mechanical Ventilation Device

External Device Group

EXPERIMENTAL

Participant in this group will be applied inspiratory muscle training with Inspiratory Muscle Training (IMT) device in addition to conventional chest physiotherapy consisting of respiratory control, diaphragmatic breathing, costal expansion exercises, postural drainage, effective coughing, in-bed ROM exercises and mobilization, twice a day until the day of extubation.

Device: External Device

Interventions

During the first week of training, ventilator trigger sensitivity will be initiated at 20% of the patient's baseline MIP (NIF). Patients will train for 5 minutes twice a day for the first days. As the training progresses, the triggering sensitivity will be gradually increased to 30% and 40% of the initial MIP and the duration will be increased up to 30 minutes. During the training sessions, participants will be elevated to a position similar to the Semi-Fowler position at an angle of approximately 45°. Vital signs will be monitored regularly. In addition, conventional chest physiotherapy consisting of respiratory control, diaphragmatic breathing, costal expansion exercises, postural drainage, effective coughing, in-bed ROM exercises and mobilization will be applied twice daily.

MV Modification Group

The IMT (Inspiratory Muscle Training) with device will commence at 20% of the value obtained from the NIF (Negative Inspiratory Force) measurement or the lowest pressure setting, depending on the patient's tolerance. The duration and intensity will be gradually increased. Once the participants are disconnected from the mechanical ventilator, the IMT device will be connected to the T-tube via a catheter mount with a Catheter Mount. Patients will be instructed to breathe against the resistance set on the IMT device. After completing 8 repetitions, the patient will be allowed to rest for a few minutes. This routine will be repeated for a total of 3 sets of 8 repetitions. In addition, conventional chest physiotherapy consisting of respiratory control, diaphragmatic breathing, costal expansion exercises, postural drainage, effective coughing, in-bed ROM exercises and mobilization will be applied twice daily.

External Device Group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ≥18 years of age,
  • Hemodynamically stable,
  • Alert and conscious(Between -2 and +2 according to Richmond Agitation and Sedation Scale score)
  • Perform at least one motor command,
  • Requiring mechanical ventilation support either with continuous spontaneous ventilation(CPAP) mode or intermittent mandatory ventilation(SIMV) mode with pressure or volume control(PSV),
  • Requiring oxygen ventilation ≤ 40%, Required pressure support ≤ 15 cmH2O, and PEEP ≤ 10 cmH2O,
  • Having a body temperature between 36- 38 °C,
  • Unable to breathe unsupported for 72 consecutive hours following the resolution of factors supporting respiratory failure,
  • Having FiO2 ≤ 0.5, PaO2 \> 60 mmHg, and capable of sufficient gas exchange,
  • Patients deemed suitable for pulmonary physiotherapy by intensive care physicians will be included in the study.

You may not qualify if:

  • Having an acute onset of illness,
  • Impaired cooperation,
  • Insufficient level of consciousness due to severe intracranial disease ,
  • Having a progressive neuromuscular disease,
  • Having an unstable neurological condition,
  • Having a psychiatric disorder and exhibiting excessive agitation (patients with Richmond Agitation and Sedation Scale (RASS) ≥ +2),
  • Having experienced any trauma to the chest wall,
  • Having thoracic deformities that affect respiration,
  • Using a high amount of sedative or analgesic agents,
  • Participants using home mechanical ventilators prior to hospital admission.
  • Criteria for Study Discontinuation:
  • Cardiac, pulmonary, and other conditions leading to impaired hemodynamic stability.
  • Impaired cooperation, compliance, and motivation.
  • Discontinuation by the intensive care physician.
  • Participants will be free to withdraw from the study at their discretion.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Health Sciences

Istanbul, 34353, Turkey (Türkiye)

Location

MeSH Terms

Interventions

External Fixators

Intervention Hierarchy (Ancestors)

Orthopedic Fixation DevicesOrthopedic EquipmentSurgical EquipmentEquipment and SuppliesSurgical Fixation Devices

Study Officials

  • Hasan Kocoglu, Prof.Dr.

    Goztepe Prof Dr Suleyman Yalcın City Hospital

    STUDY CHAIR
  • Esra Pehlivan, Ass.Prof.

    Saglik Bilimleri Universitesi

    PRINCIPAL INVESTIGATOR
  • Mehmet Burak Uyaroglu, PT,PhD(c)

    Saglik Bilimleri Universitesi

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 22, 2023

First Posted

September 21, 2023

Study Start

November 1, 2023

Primary Completion

November 10, 2024

Study Completion

November 15, 2024

Last Updated

January 23, 2025

Record last verified: 2024-01

Locations